Who owns Medpace Holdings (MEDP)? Superinvestor holders
7 superinvestors of the 157 tracked here hold Medpace Holdings (MEDP) in their latest 13F filing, with $1.5B between them. François Rochon gives it the most weight: 5.24% of the reported portfolio. In their latest reported quarter, Jim Simons (1938–2024) added; François Rochon, C.T. Fitzpatrick, Mairs & Power team and Baillie Gifford team and 2 more reduced.
Key facts
- Superinvestors holding it
- 7 of 157
- Biggest holder
- Cliff Asness, $677.3M
- Largest weight
- François Rochon, 5.24%of their portfolio
- Combined value
- $1.5B
- Bought last quarter
- 1
- Sold last quarter
- 6
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | François RochonGiverny Capital | 5.24% | $152.8M | 244.75K | ▼ Reduced 3.6% | −9.19K | Q3 2026 |
| 2 | C.T. FitzpatrickVulcan Value Partners | 1.40% | $43.8M | 70.16K | ▼ Reduced 51% | −71.58K | Q3 2026 |
| 3 | Mairs & Power teamMairs & Power | 0.50% | $53.9M | 86.34K | ▼ Reduced 0.4% | −382 | Q3 2026 |
| 4 | Jim Simons (1938–2024)Renaissance Technologies | 0.39% | $282.4M | 452.43K | ▲ Added 8.9% | +36.82K | Q3 2026 |
| 5 | Baillie Gifford teamBaillie Gifford & Co | 0.27% | $282M | 451.76K | ▼ Reduced 4.5% | −21.44K | Q3 2026 |
| 6 | Cliff AsnessAQR Capital Management | 0.24% | $677.3M | 1.28M | ▼ Reduced 5.5% | −74.87K | Q2 2026 |
| 7 | Terry SmithFundsmith | 0.13% | $16.2M | 25.94K | ▼ Reduced 50% | −26.43K | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 6 | 1.33M | $831M | 1 | 5 |
| Q2 2026 | 157 | 7 | 2.7M | $1.4B | 1 | 6 |
| Q1 2026 | 157 | 8 | 3.4M | $1.6B | 4 | 5 |
| Q4 2025 | 157 | 9 | 3.44M | $1.9B | 3 | 7 |
| Q3 2025 | 157 | 8 | 3.36M | $1.7B | 4 | 3 |
| Q2 2025 | 157 | 7 | 1.96M | $621.1M | 4 | 3 |
| Q1 2025 | 156 | 7 | 1.35M | $411.2M | 6 | 0 |
| Q4 2024 | 156 | 7 | 1.55M | $513.5M | 7 | 0 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Jim Simons (1938–2024) | 452.43K | 415.59K | 504.67K | 465.91K | 493.59K | 678.09K | 577.69K | 553.59K |
| Baillie Gifford team | 451.76K | 473.21K | 503.19K | 547.08K | 584.8K | 522.29K | — | — |
| François Rochon | 244.75K | 253.93K | 256.08K | 263.32K | 261.8K | 261.76K | 251.94K | 234.29K |
| Mairs & Power team | 86.34K | 86.72K | 85.72K | 66.67K | 69.58K | 76.19K | 32.43K | 32.41K |
| C.T. Fitzpatrick | 70.16K | 141.74K | 203.07K | 47.31K | 200.17K | 287.46K | 325.92K | 101.34K |
| Terry Smith | 25.94K | 52.37K | 62.67K | 82.57K | 127.54K | 127.54K | 127.54K | 127.54K |
| Cliff Asness | · | 1.28M | 1.35M | 1.35M | 1.03M | — | — | 480.19K |
| David Shaw (founder) | · | — | 432.6K | 528.23K | 600.14K | — | — | — |
| Paul Tudor Jones | · | — | — | 89.24K | — | — | — | — |
| Polen Capital team | — | — | — | — | — | 4.61K | 24.47K | 16.22K |
| Lee Ainslie | · | — | — | — | — | — | 10.23K | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own MEDP?
In their latest 13F filings: François Rochon (5.24% of the portfolio, $152.8M), C.T. Fitzpatrick (1.40% of the portfolio, $43.8M), Mairs & Power team (0.50% of the portfolio, $53.9M), Jim Simons (1938–2024) (0.39% of the portfolio, $282.4M), Baillie Gifford team (0.27% of the portfolio, $282M), Cliff Asness (0.24% of the portfolio, $677.3M), Terry Smith (0.13% of the portfolio, $16.2M).
Who bought MEDP last quarter?
Jim Simons (1938–2024) (added 8.9%). “Last quarter” is each investor's latest reported quarter.
Who sold MEDP last quarter?
Reduced: François Rochon (3.6% fewer shares), C.T. Fitzpatrick (51% fewer shares), Mairs & Power team (0.4% fewer shares), Baillie Gifford team (4.5% fewer shares), Cliff Asness (5.5% fewer shares), Terry Smith (50% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Medpace Holdings (MEDP)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/MEDP/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to MEDP by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.